Adocia S.A. | Small-cap | Healthcare
€6.70
0.75%
| Adocia S.A Stock Comparison:
Adocia S.A vs Abivax SAAdocia S.A vs Valneva SEAdocia S.A vs OseAdocia S.A vs Transgene S.AAdocia S.A vs Sensorion SAAdocia S.A vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2023

Income Metrics

Balance Sheet Metrics

Total Assets 27.0M
Total Liabilities 30.1M
Shareholders Equity -3.1M

Cash Flow Metrics

Revenue & Profitability Trend

Adocia S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i9.3M2.2M11.4M1.4M841.0K
Cost of Goods Sold i1.1M765.0K1.8M1.3M1.5M
Gross Profit i8.2M1.4M9.6M180.0K-616.0K
Gross Margin % i88.0%64.4%83.9%12.5%-73.2%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i8.5M10.1M17.9M11.5M13.2M
Total Operating Expenses i8.5M10.1M17.9M11.5M13.2M
Operating Income i-7.4M-14.2M-1.7M-19.4M-21.1M
Operating Margin % i-79.4%-662.5%-14.8%-1,341.1%-2,514.7%
Non-Operating Items
Interest Income i23.0K83.0K28.0K1.0K10.0K
Interest Expense i961.0K1.3M2.3M2.2M2.1M
Other Non-Operating Income-----
Pre-tax Income i-8.4M-21.2M-6.4M-22.8M-23.3M
Income Tax i952.0K2.0K476.0K029.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-9.3M-21.2M-6.9M-22.8M-23.3M
Net Margin % i-100.0%-984.3%-60.3%-1,575.8%-2,773.4%
Key Metrics
EBITDA i-6.9M-13.8M-1.2M-18.2M-20.2M
EPS (Basic) i€-1.00€-1.90€-0.90€-3.20€-3.30
EPS (Diluted) i€-1.00€-1.90€-0.90€-3.20€-3.30
Basic Shares Outstanding i1480805914087383803152770576006973639
Diluted Shares Outstanding i1480805914087383803152770576006973639

Income Statement Trend

Adocia S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i7.5M13.0M17.4M15.2M28.1M
Short-term Investments i-----
Accounts Receivable i8.6M111.0K467.0K207.0K0
Inventory i220.0K132.0K137.0K517.0K569.0K
Other Current Assets35.0K88.0K54.0K49.0K89.0K
Total Current Assets i22.4M20.2M26.3M22.1M36.4M
Non-Current Assets
Property, Plant & Equipment i3.8M3.7M4.4M3.8M3.6M
Goodwill i4.0K9.0K32.0K4.0K45.0K
Intangible Assets i4.0K9.0K32.0K4.0K45.0K
Long-term Investments-----
Other Non-Current Assets-----3.0K
Total Non-Current Assets i4.6M4.7M4.4M8.0M8.7M
Total Assets i27.0M25.0M30.6M30.1M45.2M
Liabilities
Current Liabilities
Accounts Payable i2.2M2.5M3.8M1.1M2.4M
Short-term Debt i3.3M1.8M15.7M16.2M3.0M
Current Portion of Long-term Debt-----
Other Current Liabilities13.0M12.9M1.1M1.4M1.2M
Total Current Liabilities i20.9M19.8M25.1M23.8M10.7M
Non-Current Liabilities
Long-term Debt i8.6M11.3M17.5M18.3M25.2M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities1.0K1.0K-309.0K715.0K
Total Non-Current Liabilities i9.3M12.1M18.5M20.1M28.1M
Total Liabilities i30.1M31.9M43.6M43.9M38.8M
Equity
Common Stock i1.6M1.4M873.0K727.0K702.0K
Retained Earnings i-9.3M-21.2M-6.9M-22.8M-23.3M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-3.1M-6.9M-13.0M-13.8M6.3M
Key Metrics
Total Debt i11.8M13.1M33.2M34.5M28.2M
Working Capital i1.6M404.0K1.2M-1.7M25.7M

Balance Sheet Composition

Adocia S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-9.3M-21.2M-6.9M-22.8M-23.3M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-7.8M12.2M-2.3M2.3M-114.0K
Operating Cash Flow i-15.9M-3.4M-828.0K-19.4M-22.9M
Investing Activities
Capital Expenditures i-229.0K-156.0K23.2M-361.0K-205.0K
Acquisitions i-----
Investment Purchases i-29.0K0-1.3M00
Investment Sales i018.0K000
Investing Cash Flow i-258.0K-138.0K21.9M-361.0K-204.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i04.5M6.0M6.0M7.0M
Debt Repayment i-1.6M-11.7M-10.6M-398.0K-488.0K
Financing Cash Flow i10.4M629.0K-4.6M6.6M6.5M
Free Cash Flow i-15.8M-5.1M-15.1M-19.6M-22.1M
Net Change in Cash i-5.7M-3.0M16.4M-13.1M-16.6M

Cash Flow Trend

Adocia S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -6.69
Forward P/E -4.99
Price to Book -30.51
Price to Sales 10.40
PEG Ratio -4.99

Profitability Ratios

Profit Margin -76.88%
Operating Margin 8.14%
Return on Equity 301.75%
Return on Assets -17.81%

Financial Health

Current Ratio 1.08
Debt to Equity -3.83
Beta 0.31

Per Share Data

EPS (TTM) €-0.96
Book Value per Share €-0.20
Revenue per Share €0.82

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
adoc126.1M-6.69-30.51301.75%-76.88%-3.83
Abivax SA 4.5B-22.33-597.06-196.12%0.00%-16.16
Valneva SE 644.5M70.643.33-44.11%-43.21%120.48
Ose 140.4M4.152.0886.29%44.88%72.30
Transgene S.A 136.7M-8.96-220.48%0.00%68.38
Sensorion SA 98.6M-3.531.35-49.28%0.00%2.93

Financial data is updated regularly. All figures are in the company's reporting currency.